Abstract
From the 1980s onwards, PET molecular imaging has yielded a wealth of information on the molecular and structural biology of neurodegeneration in patients with Huntington’s disease. While currently not in use for day to day diagnostic or predictive clinical purposes in patients, it may acquire new relevance. In this review I will outline its applications to the study of human preclinical and clinical disease, to our understanding of the neurobiology of HHuntington’s, as well as in the field of experimental therapeutics.
Cite
CITATION STYLE
Kremer, H. P. H. B. (2014). PET in huntington’s disease. In Pet and Spect in Neurology (pp. 655–666). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-54307-4_30
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
